Welcome & Introduction

Decoding Treatment Options for EGFRm NSCLC

Osimertinib as Adjuvant Therapy in patients with resected EGFRm Stage IB IIIA NSCLC-Updated Results from ADAURA

Pathology of Salivary Gland Cancers

Surgery in Salivary Gland Tumors

Role of RT in Salivary Gland Tumors

Systematic Therapy in Salivary Gland Tumors

Panel Discussion

Expert Comment

Closing Remarks & Vote of Thanks

Pathology of Salivary Gland Cancers

Surgery in Salivary Gland Tumors

Role of RT in Salivary Gland Tumors

Panel Discussion